Archive

Post Archive: The Research Institute

Virginia Cancer Patient “Living with (Stage 4) Cancer” Thanks to Clinical Trial

June 27, 2022
Read More

2022 Clinical Trials Day Virginia Cancer Specialists

May 20, 2022
Read More

Molecular Tumor Board offer patients diagnosed with cancer access to personalized medicine - Timothy A. McCarthy, MD

December 9, 2021
Read More

Virginia Cancer Specialists Participating in National Pilot Project to Increase Diversity in Cancer Treatment Trials

October 11, 2021
Read More

Virginia Cancer Specialists Joins MYLUNG Consortium, Aiming to Advance Use of Precision Medicine for Metastatic Non-Small Cell Lung Cancer Patients

February 4, 2021
Read More

Advancements in Science and Cancer Care Research Announced at the US Oncology Research 17th Annual Science Forum - Dr. Alex Spira

October 8, 2018
Read More

Virginia Cancer Specialists Collaborating with Caris Life Sciences to Present New Molecular Findings at the 2018 ASCO Annual Meeting

May 22, 2018
Read More

Virginia Cancer Specialists first patient successfully completes Cycle 1 of Treatment with PCM-075 combination with Low Dose Cytarabine (LDAC) AML Trial

March 6, 2018
Read More

Patient Safety for Clinical Trials is important, here are four questions to ask

February 7, 2018
Read More

Virginia Cancer Specialists enrolls fist patient in Phase 1b/2 Clinical Trial of PCM-075 for Acute Myeloid Leukemia (AML)

February 7, 2018
Read More